Skip to main content

Delfi Diagnostics Raises $100M in Series A Financing

Baltimore City-based Delfi Diagnostics Inc. cancer treatment center has raised $100M in Series A funding. The company plans to use the funding to expand its team of cancer researchers and machine learning experts to validate its novel next-generation liquid biopsy technology through multiple prospective clinical studies. The new technology platform is designed to detect and identify specific cancers in at-risk individuals. The funding round was led by multiple lenders and advised by T. Rowe Price Associates, Inc. Via

Read More

Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927